BIFIDO Co., Ltd. (KOSDAQ:238200)
South Korea · Delayed Price · Currency is KRW 2,405.00
-155.00 (-6.05%)
At close: Oct 23, 2026
BIFIDO Market Cap
BIFIDO has a market cap or net worth of 19.67 billion as of October 23, 2026. It is the 38,908th most valuable company in the world and the 2,428th biggest in South Korea. Its market cap has decreased by 34.11% in one year.
Market Cap
19.67B
Enterprise Value
22.28B
Revenue
14.63B
Global Rank
Country Rank
#2,428 South Korea
PE Ratio
10.62
ChartMarket Cap Chart
Since December 26, 2018, BIFIDO's market cap has decreased from 149.29B to 19.67B, a decrease of -86.82%. That is a compound annual growth rate of -22.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 19.67B | -21.53% |
| Dec 30, 2025 | 25.07B | 4.07% |
| Dec 30, 2024 | 24.09B | -45.16% |
| Dec 28, 2023 | 43.93B | -36.82% |
| Dec 29, 2022 | 69.53B | -22.02% |
| Dec 30, 2021 | 89.16B | -4.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Korean Drug | 32.19B |
| Korea Arlico Pharm | 30.81B |
| HLscience | 27.60B |
| Pharmsville | 26.62B |
| Baskhanbio Pharma | 24.95B |
| Seoul Pharma | 21.80B |
| Daesung Microbiological Labs. | 21.43B |
| WooGene B&G | 19.90B |